FDA's ODAC Votes in Favor of Drug to Reduce Neuroblastoma Relapse Risk ResearchJessica KeanOctober 10, 2023neuroblastoma, FDA, ODAC, DFMO, relapse, remission
Introducing CC-DIRECT, a New NCI Public-Private Partnership ResearchJessica KeanFebruary 27, 2023CC-DIRECT, NCI, CCDI, Cancer Moonshot
Presenting the 2022 Leonard M. Rosen Memorial Research Award to NCI’s Malcolm Smith ResearchJessica KeanNovember 3, 2022Rosen Award, NCI, cancer research
FDA Approves Sodium Thiosulfate to Prevent Chemo-Induced Hearing Loss in Kids ResearchJessica KeanOctober 21, 2022hearing loss, PFDD, cisplatin, PedMark, sodium thiosulfate
New Research Supports Upcoming Meeting on Cardiac Late Effects ResearchJessica KeanJune 24, 2022cardiac late effects, PFDD, cancer survivors